General MedicationsOTICGeneric

NEO-CORT-DOME

ACETIC ACID, GLACIAL; HYDROCORTISONE; NEOMYCIN SULFATE

Standard Dose

2%;1%;EQ 0.35% BASE

Max Dose

Refer to approved labeling

Primary Use

Marketing status: Discontinued

Summary

Approval overview NEO-CORT-DOME is listed in Drugs@FDA under application 050238 (NDA).

Marketing status: Discontinued Active ingredient ACETIC ACID, GLACIAL; HYDROCORTISONE; NEOMYCIN SULFATE Form and strength SUSPENSION/DROPS;OTIC - 2%;1%;EQ 0.35% BASE Sponsor BAYER PHARMS Submission history Latest submission status date: 1982-11-22 00:00:00.

Structured Monograph

Clinical summary

Approval overview NEO-CORT-DOME is listed in Drugs@FDA under application 050238 (NDA). Marketing status: Discontinued Active ingredient ACETIC ACID, GLACIAL; HYDROCORTISONE; NEOMYCIN SULFATE Form and strength SUSPENSION/DROPS;OTIC - 2%;1%;EQ 0.35% BASE Sponsor BAYER PHARMS Submission history Latest submission status date: 1982-11-22 00:00:00. Submission type: SUPPL.

Monitoring

• Marketing status: Discontinued

Interaction Notes

No interaction notes stored yet.